FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 18:54:11 14/06/2024 BST | ||
| 22.65 EUR | +0.58% |
|
| Current month | +6.33% | ||
| 1 month | -0.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 22.65 | +0.58% |
| 13/06/24 | 22.52 | -1.23% |
| 12/06/24 | 22.8 | -2.31% |
| 11/06/24 | 23.34 | +0.26% |
| 10/06/24 | 23.28 | +1.48% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 06:54 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MC2RVR |
| ISIN | DE000MC2RVR1 |
| Date issued | 17/07/2019 |
| Strike | 64.7 $ |
| Maturity | Unlimited |
| Parity | 2.67 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 23.92 € |
|---|---|
| Lowest since issue | 6.53 € |
| Spread | 0.02 € |
| Spread % | 0.09% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.4
USD
Average target price
142.7
USD
Spread / Average Target
+10.29%
- Stock Market
- Certificates
- Certificat